Esperion to Receive $150 Million Milestone Payment in June Esperion Completes Transfer of Marketing Authorization Approvals (MAAs) for NILEMDO™ (bempedoic acid) […]
Upgraded Manufacturing Process Being Used For Production Of Pivotal Stage Clinical Trial MaterialsGAINESVILLE, Fla., and CAMBRIDGE, Mass., June 22, 2020 […]